Lung Neoplasms: all 7,333 studies
Page 70 of 74. Open to participants first (1,554), then studies with results posted, then the rest; newest registration first within each.
- Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00088556Phase 1/2
- S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung CancerCompletedNCT00087412Phase 2
- Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical ResectionTerminatedNCT00087269Phase 2
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung CancerTerminatedNCT00087048Phase 2
- Romidepsin in Treating Patients With Relapsed Small Cell Lung CancerCompletedNCT00086827Phase 2
- A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsCompletedNCT00085826Phase 3
- Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerCompletedNCT00085813Phase 2
- S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00085501Phase 2
- Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00085280Not applicable
- Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00084981Phase 1
- Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00083161Phase 2
- Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung CancerStatus unknownNCT00083083Phase 2
- Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung CancerCompletedNCT00081315Phase 2
- Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00081302Phase 2
- Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based ChemotherapyCompletedNCT00081107Phase 2
- Effectiveness of KOS-862 in the Treatment of Lung CancerTerminatedNCT00080509Phase 2
- Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung CancerCompletedNCT00080080Phase 2
- Study of Motexafin Gadolinium and Docetaxel for Advanced Solid TumorsCompletedNCT00080041Phase 1
- Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)CompletedNCT00080015Phase 2
- Iscar for Supplemental Care in Stage IV Lung CancerCompletedNCT00079794Phase 2
- Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00079287Phase 3
- CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung CancerCompletedNCT00079235Phase 2
- Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsCompletedNCT00078845Phase 2
- Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CarcinomaCompletedNCT00078455Phase 2
- Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung CancerCompletedNCT00078390Phase 1/2
- A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung CancerCompletedNCT00078260Phase 3
- TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT00077883Phase 1/2
- 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00077415Phase 2
- A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung CancerCompletedNCT00077350Phase 2
- Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung LesionsCompletedNCT00077324
- Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00077311Phase 2
- ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung CancerCompletedNCT00077246Phase 1/2
- Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung CancerStatus unknownNCT00077220Phase 3
- Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00075751Phase 2
- Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00075517Phase 2
- Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00075426Phase 2
- Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00075374Phase 2
- A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With ChemotherapyCompletedNCT00074854Phase 1/2
- S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung CancerTerminatedNCT00074295Phase 2
- Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00074204Phase 3
- GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid TumorsCompletedNCT00074022Phase 1/2
- Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073866Phase 1/2
- Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073723Phase 1/2
- Vaccine Treatment for Advanced Non-Small Cell Lung CancerCompletedNCT00073398Phase 1/2
- A Study of ABT-751 in Patients With Non-Small Cell Lung CancerCompletedNCT00073151Phase 2
- Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00072631Phase 2
- Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00072527Phase 2
- Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072072Phase 1
- Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072059Phase 2
- Analysis of Brain Metastasis in Patients With Lung CancerCompletedNCT00071344
- Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00071136Phase 1/2
- CPG 7909 Injection in Non-Small Cell Lung CancerCompletedNCT00070629Phase 2
- Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00070486Phase 2
- Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00068653Phase 2
- Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00068497Not applicable
- Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyCompletedNCT00068289Phase 2
- Acupuncture for Shortness of Breath in Cancer PatientsCompletedNCT00067691Not applicable
- Study Evaluating EKB-569 in Advanced Non-Small Cell Lung CancerCompletedNCT00067548Phase 2
- Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00066885Phase 1/2
- Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerCompletedNCT00066768Phase 1
- Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsCompletedNCT00066651Phase 1
- ZD6474 in Treating Patients With Small Cell Lung CancerCompletedNCT00066313Phase 2
- Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsTerminatedNCT00064636Phase 1
- 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00064064Phase 2
- Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung CancerCompletedNCT00064012Phase 2
- Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckCompletedNCT00063895Phase 1/2
- Phase II Study in Patients With Recurrent Non-Small-Cell Lung CancerCompletedNCT00063388Phase 2
- Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based TherapyCompletedNCT00063219Phase 2
- Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung CancerStatus unknownNCT00062907Phase 1
- High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNCT00062335Phase 1
- Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00062322Phase 1
- Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
- Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00062270Phase 1/2
- Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerCompletedNCT00062179Phase 2
- Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00062101Phase 2
- Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung CancerCompletedNCT00062062Phase 2
- Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former SmokersCompletedNCT00061997Phase 1
- Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung CancerCompletedNCT00061919Phase 3
- Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00061854Phase 2
- Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate CancerCompletedNCT00059943Phase 2
- Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00059761Phase 1
- Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung CancerCompletedNCT00059605Phase 1
- Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00058006Phase 2
- Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryCompletedNCT00057798Phase 2
- Zileuton in Preventing Lung Cancer in Patients With Bronchial DysplasiaCompletedNCT00056004Phase 2
- Celecoxib in Preventing Lung Cancer in Former Heavy SmokersCompletedNCT00055978Phase 2
- Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinStatus unknownNCT00055965Phase 3
- Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00055887Phase 3
- Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00055757Phase 2
- An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung CancerCompletedNCT00054899Phase 1
- Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
- BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00054314Phase 2
- Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054210Phase 3
- Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054197Phase 3
- Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerTerminatedNCT00054184Phase 3
- Surgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00054002Phase 2
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant MesotheliomaCompletedNCT00053885Phase 2
- Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00053300Phase 2
- Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00052949Phase 2